The presence of NK cells in MHC-I-low melanoma lesions was associated with improved outcomes in the TCGA cohort [253], and NK cells were found in the proximity of melanoma cells in responders to anti-PD-1 treatment [254]. This evidence concerns the gene PDCD1 and melanoma.